Claret Medical (United States)

Alternate names: Claret Medical, Claret Medical, Inc.

Parent institution: Boston Scientific (United States)

ROR: 01pgkyz50

OpenAlex ID: I4405279575

Protection Against Cerebral Embolism During Transcatheter Aortic Valve Replacement

2016 · Samir R. Kapadia, Susheel Kodali, et al. · Journal of the American College of Cardiology · 521

Neurocognition and Cerebral Lesion Burden in High-Risk Patients Before Undergoing Transcatheter Aortic Valve Replacement

2018 · Ronald M. Lazar, Marykathryn A. Pavol, et al. · JACC: Cardiovascular Interventions · 30

Neuroendovascular Intervention: Evolving at the Intersection of Neurosurgery and Neuro-Ophthalmology

2017 · Jason M. Davies, L. Nelson Hopkins · Journal of Neuro-Ophthalmology · 2

TCT-422 Pre-procedural white matter lesion burden predicts MRI outcomes in transcatheter aortic valve replacement (TAVR): The Sentinel Trial

2017 · Michael Dwyer, Axel Linke, et al. · Journal of the American College of Cardiology

TCT-425 Impact of cerebral protection in aortic stenosis patients treated with transcatheter aortic valve replacement on functional and structural integrity of the brain: results of a combined patient-level analysis of three randomized controlled trials

2017 · Axel Linke, Samir Kapadia, et al. · Journal of the American College of Cardiology

TCT-108 Debris heterogeneity across different valve types captured by a cerebral protection system during TAVR

2017 · Tobias Schmidt, Martin Leon, et al. · Journal of the American College of Cardiology

Works count: 6

Citation count: 555